Written by Klarity Editorial Team
Published: Jul 15, 2026

Last updated: July 15, 2026
Highmark West Virginia Inc. d/b/a Highmark Blue Cross Blue Shield West Virginia is the primary Blue Cross Blue Shield licensee serving West Virginians through commercial individual, small group, and large group plans. Prescription obesity medications — including GLP-1 receptor agonists such as Wegovy (semaglutide) and Zepbound (tirzepatide) — have transformed the weight loss treatment landscape, and many West Virginia residents enrolled in Highmark WV commercial plans are now asking whether their plan may help cover these medications and the clinical visits that go with them.
This guide explains how Highmark WV coverage for weight loss treatment typically works in 2026, including the HM Health Solutions pharmacy formulary for FDA-approved weight loss medications, the Electronic Prescribing for Controlled Substances (EPCS) requirement for certain drugs, prior authorization criteria, and how to verify your specific benefits before beginning treatment.
Ready to connect with a licensed provider for weight loss care?
See if you may qualify for online weight loss treatment through Klarity Health — licensed prescribers available across West Virginia, accepting major insurance plans.
Unlike mental health and substance use disorder treatment — which is governed by West Virginia’s mental health parity statute (W. Va. Code § 33-25-8r et seq.) — weight loss treatment is not subject to state mental health parity law in West Virginia. Weight loss benefit requirements are primarily shaped by federal frameworks:
Important note on the Medicare GLP-1 Bridge: Beginning July 1, 2026, CMS launched a Medicare GLP-1 Bridge program allowing eligible Medicare Advantage Prescription Drug (MAPD) plan members to access Wegovy, Zepbound, and Foundayo at a $50/month patient cost. This program is available only to Medicare Advantage members — it does not apply to Highmark WV commercial members. If you are enrolled in a commercial Highmark WV plan (individual, small group, or large group), you are not eligible for the CMS GLP-1 Bridge.
Subject to your specific plan’s terms, deductible, and network requirements, Highmark WV commercial plans may typically provide coverage for some or all of the following weight loss services:
Coverage for bariatric surgery (gastric bypass, sleeve gastrectomy, gastric banding) varies significantly by employer plan design and is outside the scope of this guide, which focuses on medical and pharmaceutical weight loss treatment.
Highmark WV plans use HM Health Solutions — a wholly owned Highmark subsidiary — as their pharmacy benefit manager (PBM). HM Health Solutions maintains its own formulary, which is distinct from CVS/Caremark, OptumRx, and Express Scripts formularies used by other major West Virginia insurers.
In 2026, Highmark has expanded its anti-obesity coverage policies and introduced the EnReachRx program (powered by Express Scripts), a GLP-1 patient support model offering access to obesity medications through the EnGuide mail-order pharmacy and select retail partners including Costco and Walgreens. This program became effective for most commercial and Healthcare Reform members beginning January 1, 2026, and may provide additional clinical support services alongside the medication.
The following summarizes how common weight loss medications may be covered under HM Health Solutions commercial formularies. Coverage details can vary significantly between individual, small-group, and large-group plans. Always verify your specific plan’s formulary before initiating treatment.
| Medication | Active Ingredient | Formulary Tier | Prior Authorization | Notes |
|---|---|---|---|---|
| Wegovy | Semaglutide | Tier 3–4 (Specialty) | Required | Anti-Obesity Enhanced policy; BMI ≥30 + comorbidity or BMI ≥40; step therapy may apply |
| Zepbound | Tirzepatide | Tier 3–4 (Specialty) | Required | Anti-Obesity Standard policy; BMI ≥30 + comorbidity or BMI ≥40; step therapy may apply |
| Saxenda | Liraglutide | Tier 3–4 (Specialty) | Required | Non-preferred vs. Wegovy; step therapy from Wegovy/Zepbound may be required |
Anti-Obesity PA criteria (2026 typical requirements): For Wegovy and Zepbound under most HM Health Solutions commercial plans, prior authorization may require documentation of a BMI of 30 or higher with at least one weight-related comorbidity (such as hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, or cardiovascular disease), or a BMI of 40 or higher without a comorbidity. Providers typically need to document prior lifestyle/behavioral interventions and the absence of contraindications. Highmark’s December 2025 enhanced anti-obesity policy also extended coverage to members with BMI ≥40 with high-risk conditions including sleep apnea, cardiovascular disease, or advanced MASH (metabolic-associated steatohepatitis). Maintenance authorization typically requires evidence of ongoing prescriber monitoring and a clinically meaningful response to treatment.
| Medication | Active Ingredient(s) | Formulary Tier | Prior Authorization | Notes |
|---|---|---|---|---|
| Contrave | Naltrexone + Bupropion | Tier 2–3 | Often required | PA criteria typically mirror GLP-1 BMI thresholds; non-scheduled medication |
| Orlistat (Alli, Xenical) | Orlistat | Tier 1–2 | Typically not required | Lowest-tier option; non-scheduled; limited efficacy vs. GLP-1s |
| Phentermine | Phentermine | Tier 1–2 | Varies by plan | Schedule IV controlled substance; quantity limits apply; short-term use only |
| Qsymia | Phentermine + Topiramate ER | Tier 2–3 | Often required | Schedule IV controlled substance; REMS program; PA likely; quantity limits |
Coverage for prescription weight loss medications depends on whether your specific Highmark WV plan includes an anti-obesity drug benefit. Some employer-sponsored plans explicitly exclude weight loss medications from coverage. Review your plan’s Summary of Benefits and Coverage (SBC) or call HM Health Solutions member services to confirm whether your plan covers these medications before requesting a prescription.
West Virginia’s EPCS mandate — codified at W. Va. Code § 60A-4-403a — requires electronic prescribing for all controlled substances, not only Schedule II drugs. This is a broader requirement than many other states, which limit EPCS mandates to Schedule II substances.
How EPCS applies to weight loss medications in West Virginia:
For patients using telehealth providers to manage weight loss in West Virginia, EPCS compliance is handled by licensed telehealth prescribers in their platform. Patients generally do not need to take any additional steps regarding EPCS; simply confirm at your appointment that the prescriber is licensed in West Virginia and uses a DEA-registered electronic prescribing system.
Prior authorization (PA) is required for most GLP-1 receptor agonists and several other prescription weight loss medications under HM Health Solutions commercial formularies in 2026. Under West Virginia SB 267 (enacted 2024), all Highmark WV prior authorization requests — including those for weight loss medications — must be submitted through the Availity Essentials portal. Paper PA submission forms are no longer accepted for Highmark WV plans.
Typical PA documentation your provider may need to submit:
PA appeal rights: If Highmark WV denies a PA request for a weight loss medication, you have the right to request an internal appeal and, if necessary, an external independent review. Urgent or concurrent review denials may be eligible for expedited appeal processing. The West Virginia Insurance Commissioner’s office (1-888-879-9842) can provide guidance if you believe your appeal was improperly handled.
Step therapy considerations: Some Highmark WV plans may require step therapy for specialty GLP-1 medications, meaning a member may need to try and document failure or intolerance to a lower-tier weight loss option (such as Contrave or orlistat) before the plan will authorize Wegovy or Zepbound. Confirm your plan’s step therapy requirements with HM Health Solutions before your first visit.
Telehealth weight loss services — including video-based medical evaluation, prescription management, and follow-up visits — are increasingly available to West Virginia Highmark members. West Virginia’s telehealth parity statute requires fully insured Highmark WV commercial plans to cover telehealth services at parity with in-person care, meaning the plan cannot impose unique restrictions on telehealth visits that it does not also apply to comparable in-person visits.
Klarity Health offers online weight loss care with licensed providers who are available across West Virginia. Klarity providers can evaluate your eligibility for FDA-approved weight loss medications including GLP-1s, complete PA documentation for HM Health Solutions submission, and provide ongoing monitoring and support — all via video appointments.
See if your Highmark plan may cover your weight loss visit at Klarity Health.
Start your online weight loss consultation — same-day appointments available, major insurances accepted.
Because weight loss medication coverage varies significantly between Highmark WV plan designs, verifying your specific benefits before beginning treatment is strongly recommended. Here are the most reliable steps:
Highmark WV commercial plans may cover Wegovy and Zepbound through the HM Health Solutions formulary, typically under the Anti-Obesity Enhanced and Anti-Obesity Standard policies, respectively. Coverage usually requires prior authorization with documented BMI criteria and weight-related comorbidities. Not all Highmark WV plan designs include anti-obesity drug coverage — confirm with your specific plan before requesting a prescription. Coverage details vary by plan and individual circumstances.
No. The CMS Medicare GLP-1 Bridge program — which launched July 1, 2026 and provides Wegovy, Zepbound, and Foundayo at $50/month — is available only to Medicare Advantage Prescription Drug (MAPD) plan members. It does not apply to Highmark WV commercial (individual, small group, or large group) members.
No. W. Va. Code § 33-25-8r et seq., West Virginia’s mental health parity statute, applies specifically to mental health and substance use disorder benefits. It does not govern weight loss treatment or obesity medication coverage. Weight loss benefit requirements are primarily shaped by ACA Essential Health Benefits rules (for individual and small-group plans) and individual employer plan design (for large-group and self-funded plans).
Only for controlled substances. Phentermine and Qsymia are Schedule IV controlled substances and require EPCS under W. Va. Code § 60A-4-403a. GLP-1 medications (Wegovy, Zepbound, Saxenda), Contrave, and orlistat are not controlled substances and are not subject to West Virginia’s EPCS mandate.
For fully insured individual and small-group ACA-compliant plans, intensive behavioral counseling for obesity (BMI ≥30) may be covered at no cost-sharing under ACA preventive services requirements, based on the USPSTF “A” recommendation. Large-group and self-funded plans may or may not cover behavioral weight loss counseling — check your plan documents or call 1-800-544-7811.
EnReachRx is a GLP-1 patient support program launched by Highmark in partnership with Express Scripts, effective January 1, 2026 for most commercial and Healthcare Reform members. It provides access to GLP-1 medications via EnGuide mail-order pharmacy and select retail partners (Costco, Walgreens) with additional clinical support. Self-funded employer clients had the option to opt out of EnReachRx by September 10, 2025 — if your employer opted out, this program may not apply to your plan. Contact Highmark WV member services to confirm whether EnReachRx is part of your specific plan.
Under WV SB 267 (2024), all Highmark WV PA requests must be submitted electronically through Availity Essentials. Paper PA forms are not accepted. Your prescribing provider typically handles PA submission on your behalf. Allow 3 to 15 business days for standard PA review; urgent PAs may be processed within 24 to 72 hours depending on clinical circumstances.
This article is for general informational purposes only and does not constitute insurance, legal, or medical advice. Prescription drug coverage, prior authorization requirements, formulary tier placements, and benefit structures vary by plan and are subject to change. Always verify your specific plan’s benefits by reviewing your Summary of Benefits and Coverage (SBC) or contacting Highmark BCBS WV Member Services directly at 1-800-544-7811 before beginning any weight loss treatment program or requesting a prescription. Klarity Health is not affiliated with Highmark West Virginia Inc. or HM Health Solutions.
Find the right provider for your needs — select your state to find expert care near you.